Drug Trial Radar · NCT00351910
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Jan 26, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
494
Actual
Start
May 2006
Primary completion
Not stated
Study completion Apr 2007
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jul 13, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy of quetiapine fumarate sustained release (Seroquel SR™) in combination with an antidepressant versus an antidepressant alone in patients with Major Depressive Disorder. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Conditions
- Major Depressive Disorder
Interventions
QuetiapineDrug
AmitriptylineDrug
BupropionDrug
CitalopramDrug
DuloxetineDrug
EscitalopramDrug
FluoxetineDrug
ParoxetineDrug
SertralineDrug
VenlafaxineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of quetiapine fumarate sustained release
- (Seroquel SR™) in combination with an antidepressant versus an antidepressant alone in patients with Major Depressive Disorder.
Locations
72 sites in 12 countries. Site status is shown where the registry gives one.
Research Site
Brisbane, Australia
Research Site
Everton Park, Queensland, Australia
Research Site
Southport, Queensland, Australia
Research Site
Frankston, Victoria, Australia
Research Site
Malvern, Victoria, Australia
Research Site
Prahran, Victoria, Australia
Research Site
Richmond, Victoria, Australia
Research Site
Assebroek, Belgium
Research Site
Brussels, Belgium
Research Site
Ghent, Belgium
Research Site
Kortrijk, Belgium
Research Site
Liège, Belgium
Research Site
Mechelen, Belgium
Research Site
Tielt, Belgium
Research Site
Edmonton, Alberta, Canada
Research Site
Moncton, New Brunswick, Canada
Research Site
Mount Pearl, Newfoundland and Labrador, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Halifax, Nova Scotia, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Pointe-Claire, Quebec, Canada
Research Site
Brno, Czechia
Research Site
Havířov, Czechia
Research Site
Havlíčkův Brod, Czechia
Research Site
Nové Město nad Metují, Czechia
Research Site
Olomouc, Czechia
Research Site
Ostrava, Czechia
Research Site
Prague, Czechia
Research Site
Helsinki, Finland
Research Site
Jarvenpaa, Finland
Research Site
Salo, Finland
Research Site
Turku, Finland
Research Site
Angoulême, France
Research Site
Arcachon, France
Research Site
Caen, France
Research Site
Château-Gontier, France
Research Site
Élancourt, France
Research Site
Le Pecq, France
Research Site
Nîmes, France
Research Site
Paris, France
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.